PRVA vs. GH, OPCH, RDNT, BTSG, SHC, CON, SGRY, ADUS, VCYT, and PACS
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), Veracyte (VCYT), and PACS Group (PACS). These companies are all part of the "healthcare" industry.
Privia Health Group vs. Its Competitors
Guardant Health (NASDAQ:GH) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.
Guardant Health currently has a consensus target price of $53.76, suggesting a potential upside of 6.99%. Privia Health Group has a consensus target price of $27.77, suggesting a potential upside of 25.60%. Given Privia Health Group's higher probable upside, analysts clearly believe Privia Health Group is more favorable than Guardant Health.
In the previous week, Guardant Health had 11 more articles in the media than Privia Health Group. MarketBeat recorded 13 mentions for Guardant Health and 2 mentions for Privia Health Group. Guardant Health's average media sentiment score of 0.72 beat Privia Health Group's score of 0.69 indicating that Guardant Health is being referred to more favorably in the media.
Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Privia Health Group has a net margin of 0.87% compared to Guardant Health's net margin of -53.82%. Privia Health Group's return on equity of 2.32% beat Guardant Health's return on equity.
Guardant Health has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Comparatively, 10.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Privia Health Group beats Guardant Health on 11 of the 16 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 7/4/2025 by MarketBeat.com Staff
